40652-76-4

Usage

Molecular structure

The compound has a complex molecular structure consisting of a tetrahydrofuran ring and a pyrimidine-2,4-dione moiety.

Functional groups

It features a dimethylamino group and a phosphinate group attached to the tetrahydrofuran ring.

Potential applications

The compound has potential applications in medicinal chemistry and pharmaceuticals due to its structural features, which may contribute to biological activity.

Further study required

The precise properties and potential uses of 1-[2-(dimethylamino)-2-oxidotetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-6-yl]-5-methylpyrimidine-2,4(1H,3H)-dione would likely require further study and exploration in a laboratory setting.

Molecular weight

The molecular weight of 1-[2-(dimethylamino)-2-oxidotetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-6-yl]-5-methylpyrimidine-2,4(1H,3H)-dione is approximately 308.24 g/mol.

Stereochemistry

The compound may have stereoisomers due to the presence of chiral centers in the molecule.

Solubility

The solubility of 1-[2-(dimethylamino)-2-oxidotetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-6-yl]-5-methylpyrimidine-2,4(1H,3H)-dione in various solvents would depend on its polarity and hydrogen bonding capabilities.

Stability

The stability of 1-[2-(dimethylamino)-2-oxidotetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-6-yl]-5-methylpyrimidine-2,4(1H,3H)-dione under different conditions (e.g., temperature, pH, light exposure) would need to be determined.

Synthesis

The synthesis of 1-[2-(dimethylamino)-2-oxidotetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-6-yl]-5-methylpyrimidine-2,4(1H,3H)-dione would likely involve multiple steps, including the formation of the tetrahydrofuran ring, the introduction of the dimethylamino and phosphinate groups, and the formation of the pyrimidine-2,4-dione moiety.

Reactivity

The reactivity of 1-[2-(dimethylamino)-2-oxidotetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-6-yl]-5-methylpyrimidine-2,4(1H,3H)-dione with various reagents and under different conditions would need to be studied to understand its potential applications and limitations.

Biological activity

The compound's potential biological activity would need to be evaluated through in vitro and in vivo assays to determine its efficacy and safety as a drug candidate.

Toxicity

The toxicity of 1-[2-(dimethylamino)-2-oxidotetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-6-yl]-5-methylpyrimidine-2,4(1H,3H)-dione would need to be assessed to ensure its safety for use in pharmaceutical applications.

Metabolism

The metabolic pathways and potential metabolites of 1-[2-(dimethylamino)-2-oxidotetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-6-yl]-5-methylpyrimidine-2,4(1H,3H)-dione would need to be investigated to understand its pharmacokinetics and pharmacodynamics.

Drug-drug interactions

The potential for drug-drug interactions with 1-[2-(dimethylamino)-2-oxidotetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-6-yl]-5-methylpyrimidine-2,4(1H,3H)-dione would need to be evaluated to ensure its safety and efficacy when used in combination with other medications.